Latest Trends Biosurgery Market By International Top 10 Vendors Size, Shares, Revenue and Forecasts Till 2026

1
Biosurgery Market
At a CAGR
of 5.7
2
The prominent players in this market are Johnson
Johnson (US), Baxter International Inc. (US),
Medtronic Plc (Ireland), Becton, Dickinson Co.
(US),
The report "Biosurgery Market by Product Type
(Sealants, Hemostats, Adhesion Barrier, Soft
Tissue Attachments, Biological Meshes, DBM, Bone
Graft Substitutes), Application (Orthopedic,
Cardiovascular), End User (Hospitals, Clinics) -
Global Forecast to 2026", is projected to reach
USD 16.0 billion by 2026 from USD 12.2 billion
in 2021, at a CAGR of 5.7 during the forecast
period.
B. Braun Melsungen AG (Germany), Stryker Corp.
(US), Integra Lifesciences Holdings Corp. (US),
CSL Ltd. (Australia), Hemostasis LLC. (US),
Pfizer Inc. (US), Cyrolife Inc. (US), Zimmer
Biomet (US), Kuros Biosciences AG (Switzerland),
Orthofix Medical Inc. (US), and Smiths Nephew
Plc. (UK).
3
Johnson Johnson (US) held the leading position
in the biosurgery market in 2020. The company
offers a wide range of biosurgery products
including bone graft substitutes, soft tissue
attachments, hemostats, staple line reinforcement
agents, and surgical sealants and adhesives. The
company has a strong geographic presence
established through its manufacturing and
distribution facilities, across the globe. The
company leverages its research capabilities and
innovative product portfolio to ensure a leading
position in the biosurgery market. In FY2020,
company invested about USD 12.2 Billion in RD,
out of which about USD 2.1 billion were invested
in Medical Devices business segment, an increase
of 9.8 in comparison to FY2019. Medtronic Plc
(Ireland) held the second position in the global
biosurgery market. Company has exhaustive
product portfolio, specifically in bone graft
substitutes and soft tissue attachment category.
Additionally, the company leverages its research
capabilities and innovative product portfolio to
ensure a leading position in the biosurgery
market. In FY2020, the company invested USD 2,331
million in RD, up from USD 2253 million in
FY2018. Medtronic focuses on organic growth
strategies such as innovation, product launch and
approval for its growth in the biosurgery
market, as evidenced by its recent product
approval and launches during FY2018 to FY2019
across orthopedic and spine surgery portfolio.
4
The surgical sealants and adhesives segment is
expected to grow at the highest CAGR The
orthopedic segment accounted for the largest
share Hospitals segment accounted for the
largest share Asia Pacific is expected to show
the highest growth rate
5
MarketsandMarkets INC. About Us
Facebook
LinkedIn
MarketsandMarkets provides quantified B2B
research on 30,000 high growth niche
opportunities/threats which will impact 70 to
80 of worldwide companies revenues. Currently
servicing 7500 customers worldwide including 80
of global Fortune 1000 companies as clients.
Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets
for their painpoints around revenues decisions.
Twitter
630 Dundee Road Suite 430 Northbrook, IL
60062 USA 1-888-600-6441
sales_at_marketsandmarket s.com